All News

The phase 3 MAGNOLIA trial will assess whether abelacimab can prevent venous thromboembolism recurrence in patients with gastrointestinal or genitourinary cancers.

From the death of a football Hall of Famer and a golf champion to actress and former Nickelodeon star Jennette McCurdy discussing her mother’s breast cancer in her memoir, “I’m Glad My Mom Died,” here’s what’s happening in the cancer space this week.

Receiving a pancreatic cancer diagnosis has caused me to reexamine my spirituality, which led me to believe that my life is a line, rather than a single dot in time.

More patients with pretreated non-small cell lung cancer saw their disease disappear with abivertinib compared to Tagrisso.

Here's a step-by-step guide on how I drew the superhero that I wish existed to fight my wife's cancer.

Cervical cancer survivor Ginny Marable heard about a story of a fellow cervical cancer survivor, Tamika Felder, not being able to preserve her fertility. The story moved Marable so much that she and her husband donated their embryos to Felder.

In recent years, immunotherapy’s usage has expanded for the treatment of patients with kidney cancer.

The FDA approved Imbruvica for children over the age of 1 who are experiencing chronic GVHD that has already been treated by one or more prior therapy.

Radiotherapy with standard of care for the treatment of patients with low-burden metastatic prostate cancer had minimal effects on quality of life over a five-year follow-up period.

Patients with stage 3 melanoma who had metastases larger than 0.3 millimeters had poorer survival outcomes and may benefit from adjuvant therapy, recent findings showed.

Patients with malignant pleural mesothelioma tended to have prolonged benefit when treated with Keytruda plus Lenvima in the PEMMELA clinical trial.

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

When doctors told me that there was no more they could do for my stage 4 lung cancer, I refused to believe them, and wish other patients did the same.

From bald heads paired with lush eyebrows to the typical emaciated patient, there are certain tropes of how cancer is portrayed on TV that bother me, as they do not represent the experiences of everyone with the disease.

CURE® surveyed its audience to see how they cope with fear of cancer recurrence. Here’s what they had to say.

Treatment with Ayvakit was associated with promising outcomes in patients with mastocytosis, according to findings from the PIONEER trial.

My doctor once told me that if you're old enough to fight for your country, then you're old enough to get breast cancer.

Adding the investigational cancer drug lanraplenib to Xospata, if found to be effective, may broaden treatment options for patients with relapsed/refractory FLT3-mutated acute myeloid leukemia.

As I reflect on four years of “warriorhood” since being diagnosed with cancer, I wrote a letter to my younger self and others who are just receiving diagnosis.

The death of “Grease” star Olivia Newton-John from metastatic breast cancer has triggered discussions about the specifics of the disease. Here, CURE® details what metastatic breast cancer is.

The combination treatment demonstrated survival and safety results similar to those of chemotherapy for patients with advanced, untreated follicular lymphoma.

Janet M. McFadden, RN-BC, B.S., MT(ASCP) understands the medical issues her patients are facing. She is calm and compassionate with her patients.

Often patients read online profiles of medical providers to decide where to receive care. In reality, having a nurse like Christine is so much more important.

The FDA has allowed the manufacturer of emavusertib to continue a phase 1/2 study investigating effects of the treatment in patients with lymphoma.

I am still here fighting, fighting hard and I will continue to do so to make sure I have more graduations, more weddings, and more everything that I can squeeze into my precious time left here on earth.

From ESPN analyst Dick Vitale announcing he is cancer-free months following a lymphoma diagnosis to a Speedo-clad race in South Africa to raise awareness for cancer, here’s what’s happening in the oncology space this week.

Not only does she have incredible clinical intuition and ability, but she has a deep compassion and commitment to her patients that is truly unparalleled.

A representative of the company developing the investigational CAR-T cell therapy noted that they hypothesize that the combination “has the potential to further enhance efficacy and provide patients with a chemotherapy-sparing, second-line treatment option.”